The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population

Journal of Viral Hepatitis

Volumn 18, Issue 4, 2011, Pages

  McDonald, Scott A ^a   Hutchinson, S J ^a,b   Mills, P R ^c   Bird, S M ^b,d   Cameron, S ^c   Dillon, J F ^e   Goldberg, D J ^a  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Alcohol; Hepatitis C; Hospital admissions; Injecting drug users; Liver disease

Indexed keywords

ALCOHOL; VIRUS ANTIBODY; VIRUS RNA;

ARTICLE; DRUG USE; FEMALE; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HOSPITALIZATION; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; RISK ASSESSMENT; RNA, VIRAL; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79952144372     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01380.x     Document Type: Article

References (19)

1. Campbell J, Hagan H, Latka M et al. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend 2006; 81(3): 259-265. (Pubitemid 43152452)
2. Health Protection Agency. Hepatitis C in UK: annual report 2009. 2009.
3. Goldberg D, Davis B, Allardice G, McMenamin J, Codere G. Monitoring the spread of HIV and AIDS in Scotland 1983-1994. Scott Med J 1996; 41(5): 131-138.
4. Kendrick S, Clarke J. The Scottish record linkage system. Health Bull (Edinb) 1993; 51: 72-79.
5. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stat 1982; 10: 1100-1120.
6. Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. BMJ 1996; 312(7027): 364-367. (Pubitemid 26049407)
7. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna; Austria: R Foundation for Statistical Computing, 2008.
8. Page-Shafer K, Pappalardo BL, Tobler LH et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 2008; 46(2): 499-506. (Pubitemid 351231293)
9. Page K, Hahn JA, Evans J et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009; 200(8): 1216-1226.
10. McDonald SA, Hutchinson S, Bird S et al. Association of self-reported alcohol use and hospitalisation for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction 2009; 104(4): 593-602.
11. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284(4): 450-456. (Pubitemid 30484478)
12. Hutchinson S, Roy K, Wadd S et al. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scott Med J 2006; 51(2): 8-15.
13. Harris HE, Ramsay ME, Andrews N, Eldridge KP. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002; 324(7335): 450-453. (Pubitemid 34169458)
14. Ostapowicz G, Bell SJ, Desmond PV. Severity of liver disease in hepatitis C infection contracted through injecting drug use. Aust N Z J Med 1999; 29(6): 776-781. (Pubitemid 30036067)
15. Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. Epidemiology and economic burden of viral hepatitis: an observational population based study. Gut 2002; 50(1): 100-105. (Pubitemid 34028311)
16. Gidding HF, Amin J, Dore GJ, Ward K, Law MG. Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales. J Hepatol 2010; 53(1): 43-49.
17. Taylor A, Goldberg D, Hutchinson S et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working.
18. University of the West of Scotland, Health Protection Scotland, West of Scotland Specialist Virology Centre. The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and Injecting Risk Behaviours Among Injecting Drug Users Attending Needle Exchanges in Scotland, 2008/2009. Paisley: University of the West of Scotland, 2010.
19. McDonald SA, Hutchinson SJ, Cameron S et al. Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007. J Viral Hepat 2010; (In Press).